台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台裕化學製藥廠股份有限公司 新竹縣竹東鎮員山路11巷13弄1號 (47066452) - poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da);;sodium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium chloride;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;malic acid - 注射液 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) (trihydrous)mg; calcium chloride dihydrate (4012000350) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da) (9600009069) mg; malic acid (9600017800) mg - electrolytes in combination with other drugs - 單獨使用晶質輸注液無法治療且無其他合適替代療法可用之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

和聯生技藥業股份有限公司 台北市敦化北路３１１號５樓 (04270075) - poly(o-2 hydroxyethyl )starch;;sodium chloride;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium chloride - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; poly(o-2 hydroxyethyl )starch (9600030283) (molar substitution 0.42, mw130,000)mg - hydroxyethylstarch - 預防及治療血容積低下及休克

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣武田藥品工業股份有限公司 台北市南京東路三段２１７號７Ｆ (03564609) - sodium chloride;;potassium chloride;;boric acid;;sodium borate (sodium biboratesodium tetraborate;;hydroxyethyl cellulose;;edetate disodium (eq to disodium edetate)( eq to e.d.t.a. disodium) (eq to edta -2na);;polysorbate 80(tween 80)(sorbimacrogol oleate300;;chlorhexidine gluconate - 點眼液劑 - potassium chloride (4012001800) 1.5mg; sodium chloride (4012002100) 5.5mg; chlorhexidine gluconate (5204900231) (0.00025ml) 0.05mg; sodium borate (sodium biboratesodium tetraborate (5228000100) 0.5mg; hydroxyethyl cellulose (5236000500) 1.0mg; edetate disodium (eq to disodium edetate)( eq to e.d.t.a. disodium) (eq to edta -2na) (6400000310) 0.1mg; boric acid (8404600600) 5.0mg; polysorbate 80(tween 80)(sorbimacrogol oleate300 (9600023500) 0.0015ml - other ophthalmologicals - 配戴隱形眼鏡時用以預防乾燥感、異物感、搔癢感、霧視及眼睛疲勞。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

中國化學製藥股份有限公司新豐工廠 新竹縣新豐鄉坑子口１８２之１號 (03088802) - sodium chloride;;poly(o-2 hydroxyethyl)starch (molar subs 0.38-0.45; average molecular weight 130000) - 靜脈輸注液 - sodium chloride (4012002100) mg; poly(o-2 hydroxyethyl)starch (molar subs 0.38-0.45; average molecular weight 130000) (9600009068) mg - blood substitutes and plasma protein fractions - 治療及預防血容積減少(hypovolaemia)，急性正常容積血液稀釋法(anh：acute normovolaemic haemodilution technique)。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - sodium chloride;;poly(o-2 hydroxyethyl)starch (molar subs 0.38-0.45; average molecular weight 130000) - 注射劑 - sodium chloride (4012002100) gm; poly(o-2 hydroxyethyl)starch (molar subs 0.38-0.45; average molecular weight 130000) (9600009068) mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療且無其他合適替代療法可用之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

杏林新生製藥股份有限公司 桃園市龍潭區三和里店湖一路237號 (33122166) - sodium chloride;;potassium chloride;;calcium chloride;;sodium lactate;;glucose;;hydroxyethyl starch 70000 - 注射劑 - sodium lactate (4008000900) ( 60 w/v%)mg; calcium chloride (4012000300) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; glucose (4020000700) 10mg; hydroxyethyl starch 70000 (9600009062) mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療且無其他合適替代療法可用之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

安強藥業股份有限公司 台北市松山區復興北路311號4樓 (12494149) - hydroxyethyl starch (200/0.5) - 注射劑 - hydroxyethyl starch (200/0.5) (9600009067) mg - hydroxyethylstarch - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

東信化學藥品有限公司 台北市吉林路４５號６樓 (11328755) - hydroxyethyl methylcellulose - （粉） - 主成分 (.) ; hydroxyethyl methylcellulose (9600015400) - blood substitutes and plasma protein fractions - 血液增量劑。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

智擎生技製藥股份有限公司 台北市中山區民生東路三段10號11樓 (80264691) - irinotecan hydrochloride - 注射劑 - irinotecan hydrochloride (1004002210) equivalent to irinotecan free base.....4.3mgmg - irinotecan - onivyde (irinotecan微脂體注射劑)適用於轉移性胰腺癌，合併5-fluorouracil和leucovorin治療曾接受過gemcitabine的患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

和聯生技藥業股份有限公司 台北市敦化北路３１１號５樓 (04270075) - poly(o-2 hydroxyethyl )starch - 注射劑 - poly(o-2 hydroxyethyl )starch (9600030283) mg - hydroxyethylstarch - 血容積低下及休克、血液稀釋、急性正容積血液稀釋(anh)。